世界の乾癬治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Psoriasis Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4783 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、乾癬治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TNF阻害剤、PDE4阻害剤、インターロイキンブロッカー、その他）、用途別市場規模（経口、非経口、局所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・乾癬治療薬の市場動向 ・企業の競争状況、市場シェア ・乾癬治療薬の種類別市場規模と予測2016-2027（TNF阻害剤、PDE4阻害剤、インターロイキンブロッカー、その他） ・乾癬治療薬の用途別市場規模と予測2016-2027（経口、非経口、局所） ・乾癬治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・乾癬治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・乾癬治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・乾癬治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・乾癬治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Astellas Pharma Inc.、AstraZeneca plc、Boehringer Ingelheim GmbH、F. Hofffmann-La Roche、GlaxoSmithKline plc、Merck & Co., Inc.、Valeant Pharmaceuticals International, Inc.、Biocon Limited、Eli Lilly and Company、G & W Laboratories Inc.） ・結論

Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to stop the skin cells from growing so quickly. The therapeutic approach for psoriasis depends upon the severity and amount of skin affected by the same.

Market Analysis and Insights: Global Psoriasis Therapeutics Market
The global Psoriasis Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psoriasis Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psoriasis Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psoriasis Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psoriasis Therapeutics market.

Global Psoriasis Therapeutics Scope and Market Size
Psoriasis Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others

Segment by Application
Oral
Parenteral
Topical

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriasis Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2016-2027)
2.2 Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Psoriasis Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Psoriasis Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Psoriasis Therapeutics Industry Dynamic
2.3.1 Psoriasis Therapeutics Market Trends
2.3.2 Psoriasis Therapeutics Market Drivers
2.3.3 Psoriasis Therapeutics Market Challenges
2.3.4 Psoriasis Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psoriasis Therapeutics Revenue
3.4 Global Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2020
3.5 Psoriasis Therapeutics Key Players Head office and Area Served
3.6 Key Players Psoriasis Therapeutics Product Solution and Service
3.7 Date of Enter into Psoriasis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2022-2027)

5 Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Psoriasis Therapeutics Market Size (2016-2027)
6.2 North America Psoriasis Therapeutics Market Size by Type
6.2.1 North America Psoriasis Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Psoriasis Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Psoriasis Therapeutics Market Size by Type (2016-2027)
6.3 North America Psoriasis Therapeutics Market Size by Application
6.3.1 North America Psoriasis Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Psoriasis Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Psoriasis Therapeutics Market Size by Application (2016-2027)
6.4 North America Psoriasis Therapeutics Market Size by Country
6.4.1 North America Psoriasis Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Psoriasis Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2016-2027)
7.2 Europe Psoriasis Therapeutics Market Size by Type
7.2.1 Europe Psoriasis Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Psoriasis Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Psoriasis Therapeutics Market Size by Type (2016-2027)
7.3 Europe Psoriasis Therapeutics Market Size by Application
7.3.1 Europe Psoriasis Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Psoriasis Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Psoriasis Therapeutics Market Size by Application (2016-2027)
7.4 Europe Psoriasis Therapeutics Market Size by Country
7.4.1 Europe Psoriasis Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Psoriasis Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Psoriasis Therapeutics Market Size by Type
8.2.1 Asia-Pacific Psoriasis Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Psoriasis Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Psoriasis Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Application
8.3.1 Asia-Pacific Psoriasis Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Psoriasis Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Psoriasis Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Psoriasis Therapeutics Market Size by Region
8.4.1 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Psoriasis Therapeutics Market Size (2016-2027)
9.2 Latin America Psoriasis Therapeutics Market Size by Type
9.2.1 Latin America Psoriasis Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Psoriasis Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Psoriasis Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Psoriasis Therapeutics Market Size by Application
9.3.1 Latin America Psoriasis Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Psoriasis Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Psoriasis Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Psoriasis Therapeutics Market Size by Country
9.4.1 Latin America Psoriasis Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Psoriasis Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type
10.2.1 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Psoriasis Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Application
10.3.1 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Psoriasis Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Psoriasis Therapeutics Market Size by Country
10.4.1 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2016-2021)
11.1.5 Astellas Pharma Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2016-2021)
11.2.5 AstraZeneca plc Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2016-2021)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Details
11.4.2 F. Hofffmann-La Roche Business Overview
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2016-2021)
11.4.5 F. Hofffmann-La Roche Recent Development
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Details
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline plc Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2016-2021)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Details
11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2016-2021)
11.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
11.8 Biocon Limited
11.8.1 Biocon Limited Company Details
11.8.2 Biocon Limited Business Overview
11.8.3 Biocon Limited Psoriasis Therapeutics Introduction
11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2016-2021)
11.8.5 Biocon Limited Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2016-2021)
11.9.5 Eli Lilly and Company Recent Development
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Details
11.10.2 G & W Laboratories Inc. Business Overview
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2016-2021)
11.10.5 G & W Laboratories Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of PDE4 Inhibitors
Table 4. Key Players of Interleukin Blockers
Table 5. Key Players of Others
Table 6. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Psoriasis Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Psoriasis Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Psoriasis Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Psoriasis Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Psoriasis Therapeutics Market Share by Regions (2022-2027)
Table 12. Psoriasis Therapeutics Market Trends
Table 13. Psoriasis Therapeutics Market Drivers
Table 14. Psoriasis Therapeutics Market Challenges
Table 15. Psoriasis Therapeutics Market Restraints
Table 16. Global Psoriasis Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Psoriasis Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2020)
Table 19. Ranking of Global Top Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Psoriasis Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psoriasis Therapeutics Product Solution and Service
Table 23. Date of Enter into Psoriasis Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Psoriasis Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Psoriasis Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Psoriasis Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Psoriasis Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Psoriasis Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Psoriasis Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Psoriasis Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Psoriasis Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Psoriasis Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Psoriasis Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Astellas Pharma Inc. Company Details
Table 64. Astellas Pharma Inc. Business Overview
Table 65. Astellas Pharma Inc. Psoriasis Therapeutics Product
Table 66. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Astellas Pharma Inc. Recent Development
Table 68. AstraZeneca plc Company Details
Table 69. AstraZeneca plc Business Overview
Table 70. AstraZeneca plc Psoriasis Therapeutics Product
Table 71. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 72. AstraZeneca plc Recent Development
Table 73. Boehringer Ingelheim GmbH Company Details
Table 74. Boehringer Ingelheim GmbH Business Overview
Table 75. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product
Table 76. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Boehringer Ingelheim GmbH Recent Development
Table 78. F. Hofffmann-La Roche Company Details
Table 79. F. Hofffmann-La Roche Business Overview
Table 80. F. Hofffmann-La Roche Psoriasis Therapeutics Product
Table 81. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 82. F. Hofffmann-La Roche Recent Development
Table 83. GlaxoSmithKline plc Company Details
Table 84. GlaxoSmithKline plc Business Overview
Table 85. GlaxoSmithKline plc Psoriasis Therapeutics Product
Table 86. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline plc Recent Development
Table 88. Merck & Co., Inc. Company Details
Table 89. Merck & Co., Inc. Business Overview
Table 90. Merck & Co., Inc. Psoriasis Therapeutics Product
Table 91. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Merck & Co., Inc. Recent Development
Table 93. Valeant Pharmaceuticals International, Inc. Company Details
Table 94. Valeant Pharmaceuticals International, Inc. Business Overview
Table 95. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product
Table 96. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Valeant Pharmaceuticals International, Inc. Recent Development
Table 98. Biocon Limited Company Details
Table 99. Biocon Limited Business Overview
Table 100. Biocon Limited Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Biocon Limited Recent Development
Table 102. Eli Lilly and Company Company Details
Table 103. Eli Lilly and Company Business Overview
Table 104. Eli Lilly and Company Psoriasis Therapeutics Product
Table 105. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 106. Eli Lilly and Company Recent Development
Table 107. G & W Laboratories Inc. Company Details
Table 108. G & W Laboratories Inc. Business Overview
Table 109. G & W Laboratories Inc. Psoriasis Therapeutics Product
Table 110. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2016-2021) & (US$ Million)
Table 111. G & W Laboratories Inc. Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psoriasis Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. TNF Inhibitors Features
Figure 3. PDE4 Inhibitors Features
Figure 4. Interleukin Blockers Features
Figure 5. Others Features
Figure 6. Global Psoriasis Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Oral Case Studies
Figure 8. Parenteral Case Studies
Figure 9. Topical Case Studies
Figure 10. Psoriasis Therapeutics Report Years Considered
Figure 11. Global Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Psoriasis Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Psoriasis Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Psoriasis Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Psoriasis Therapeutics Market Share by Players in 2020
Figure 16. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psoriasis Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2020
Figure 18. Global Psoriasis Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Psoriasis Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Psoriasis Therapeutics Market Share by Region (2016-2027)
Figure 40. China Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Psoriasis Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Psoriasis Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Psoriasis Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Psoriasis Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 60. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 61. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 62. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 63. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 64. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 65. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 66. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 67. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 68. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---